Six Courageous Doctors Testify Before U. S. Senate Committee on COVID Treatments

Dec 9, 2020 by

“Six Courageous Doctors Testify Before U. S. Senate Committee on COVID Treatments”

12.8.20

https://mailchi.mp/aapsonline/senate-hearing-2?e=f3e49d191d

*THE FOLLOWING ARE COMMENTS SENT TO DONNA GARNER FROM A WELL-RESPECTED MEDICAL DOCTOR AS HE REACTS TO THE U. S. SENATE COMMITTEE HEARING UNDER CHAIR RON JOHNSON – DETAILS FROM THAT CONFERENCE ARE POSTED FURTHER ON DOWN THE PAGE:

Very early on in the pandemic, many of us advocated HCQ+Zn±Azithromycin as EARLY outpatient treatment for the CCP virus.  Based on laboratory evidence and proof of concept trials in France, it was a no-brainer. The logic was solid:

  • Early treatment of infections is always better than treatment when the infection is more severe.
  • Early treatment, if successful, prevents hospitalization, morbidity, and mortality.
  • The drugs used are safe and have a very long track record in use around the world.
  • Because of the safety profile of the drugs, failure of early treatment imposes no morbidity and mortality burden…without it, a patient is simply back to the CDC approach which is “go home and wait until you are sick enough to be admitted.”

Instead of this logical approach with the HCQ protocol, the following happened:

  • Early HCQ+Zn treatment was politicized (TDS – Trump Derangement Syndrome), declared dangerous from a cardiac standpoint (falsely), and removed from the available formulary in many venues.
  • HCQ was condemned as ineffective because WHO trials used toxic doses, used the drug late in the course (different disease later), and in a couple of well-designed trials (Boulware et.al.), used too high a dose and used it without supplemental zinc.
  • AAPS [Association of American Physicians and Surgeons] and America’s Frontline doctors were a voice crying in the wilderness with data to back up the claims of success….but were condemned and ignored.
  • Many corporate health systems (e.g., University Hospital, St. Joseph Mercy Health System, Michigan Medicine, Baylor Scott & White, Methodist HealthCare System, etc. ) instructed their “employee doctors” not to use HCQ…corporate medicine is part of the politicization of medicine.

The major problem was the politicization of medicine. I think there are several reasons for this disaster:

  • The CDC needed hospitalized patients to fulfill their flawed primary interests of new drug development and development of vaccines.
  • Corporate medicine benefited from hospitalizations and “extra” payments from hospitalization of those diagnosed with COVID 19.
  • Corporate medicine can control the behavior of their “employee” doctors.
  • Fear mongering by CDC and the press have completely indoctrinated our society (largely as a function of the Trump Derangement syndrome).

But the good news is that brave doctors and the AAPS have stood their ground in the advocacy of early treatment.  Ivermectin has proved as effective as HCQ as a basis for treatment, and doxycycline has proved as effective as Azithromycin in combination with HCQ+Zn which is good news for QT patients. [QT is the time it takes for the heart to contract and relax].

I am happy that there are still independent, thoughtful doctors who are free of corporate limitations and willing to do the right thing for their patients.

============================

“EARLY TREATMENT SAVES LIVES – AAPS TESTIFIES BEFORE U. S. SENATE – DEC. 8, 2020”

Tuesday morning six courageous physicians, subject to attack before they even spoke a word, testified before the U.S. Senate Committee on Homeland Security and Governmental Affairs in Part II of a hearing organized by Chairman Ron Johnson titled, “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution.”

We are honored that AAPS Executive Director, Jane M. Orient, M.D., was among those invited to speak out in support of removing obstacles blocking patient access to lifesaving outpatient therapies for COVID-19. In fact, FOX News radio featured an excerpt from Dr. Orient’s testimony in the hourly news update at 1pm Eastern.


Extremely urgent updates were provided to the committee.


A summary of the hearing is available at: 
https://covexit.com/second-senate-hearing-about-outpatient-treatment-for-covid-19-highlights/

We encourage you to take particular note of the evidence that ivermectin prevents infection and reduces mortality presented by Pierre Kory, M.D. in his testimony: 
https://www.hsgac.senate.gov/imo/media/doc/Testimony-Kory-2020-12-08.pdf

A press conference with Dr. Kory and his colleagues held last week in Houston is available at: 
https://www.youtube.com/watch?v=4V3yxrJwJQs

You can also watch the full video of the hearing and download written copies of the testimony at: 
https://www.hsgac.senate.gov/early-outpatient-treatment-an-essential-part-of-a-covid-19-solution-part-ii

Highlights from Part I of the hearing, held last month, are available here: 
https://covexit.com/live-senate-hearing-about-early-outpatient-treatment/
In case you missed it — or want to review it again — a video is available of last week’s “Doctors Are In” webinar series featuring a presentation by Melanie Sturm, MBA on “The Six Powers of Persuasion – Increasing the Effectiveness of Your Communication with Patients, Policymakers, the Media, and Others.”

In the coming months and upcoming year policy battles that impact the future of American medicine will become even more fierce. Effective communication will be a crucial tool in winning these battles. Please watch this presentation to help make sure you are well equipped to convey the message of medical freedom as persuasively as possible:

“SIX POWERS OF PERSUASION” – PLEASE WATCH THIS VIDEO: 
https://www.youtube.com/watch?v=nSLWLo3Wiss
P.S. If you are a physician offering early treatment for COVID-19, and have not already added your name to the list of practices available to patients, please consider listing it: https://aaps.wufoo.com/forms/qdkwwot0n65yig/
A link to the list, as well as lists of related protocols, studies, and more is being curated at: 
https://c19protocols.com/
Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.